Cybin

CYBN • AMEX

Cybin is a biotechnology company in the healthcare sector on AMEX, led by Doug Drysdale, with a market cap of $333.3M. As of Q3 2025, 36% of shares are held by 71 institutional investors, with TANG CAPITAL MANAGEMENT LLC as the largest holder at 7.27%.

Chief Executive OfficerDoug Drysdale

Market Cap$333.3M

Biotechnology

Healthcare

Employees50.0

Websitecybin.com

Overview

Overview of institutional ownership in CYBN as of Q3 2025 with a market cap of $148.4M

All Institutions

Institutions: 71
Value Held: $54.0M
Shares Held: 9.2M
Avg Position: $760.8K
Median Position: $48.5K

Hedge Funds

Hedge Funds: 9
Value Held: $16.1M
Shares Held: 2.7M
Avg Position: $1.8M
Median Position: $471.2K

Ownership Breakdown

Institutional (non-HF)

25.57%

$37.9M

Hedge Funds

10.83%

$16.1M

Retail & Other

63.59%

$94.3M

Based on market cap of $148.4M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in CYBN as of Q3 2025

Institution	Key People	Position Value	Ownership	Owned Since	Total AUM (Long)
T TANG CAPITAL MANAGEMENT LLC Institution	-	$10.8M 0.42% of portfolio	7.27% 1.8M shares	Q3 2024 Held for 1y 2m	$2.5B
R Rosalind Advisors, Inc. Institution	-	$8.8M 3.35% of portfolio	5.96% 1.5M shares	Q1 2024 Held for 1y 8m	$263.6M
Point72 Asset Management, L.P. Hedge Fund•Multi-Strategy	Steven Alan Cohen CEO	$7.3M 0.02% of portfolio	4.92% 1.2M shares	Q4 2024 Held for 11 months	$43.2B
Deep Track Capital, LP Hedge Fund•Long/Short	David Eric Kroin CIO	$5.9M 0.17% of portfolio	3.97% 1.0M shares	Q1 2024 Held for 1y 8m	$3.5B
A ACORN CAPITAL ADVISORS, LLC Venture Capital	Anthony Michael Gallo CCO	$4.3M 2.19% of portfolio	2.92% 734.4K shares	Q4 2024 Held for 11 months	$197.0M
S SPHERA FUNDS MANAGEMENT LTD. Institution	-	$2.2M 0.52% of portfolio	1.47% 370.4K shares	Q1 2024 Held for 1y 8m	$416.3M
UBS Group AG Institution	Sergio P. Ermotti CEO	$1.8M 0.00% of portfolio	1.21% 303.7K shares	Q4 2022 Held for 2y 11m	$511.54B
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity	-	$1.6M 0.00% of portfolio	1.09% 273.8K shares	Q4 2024 Held for 11 months	$67.9B
MORGAN STANLEY RIA/Wealth	Jed Finn CEO	$1.3M 0.00% of portfolio	0.90% 227.7K shares	Q3 2021 Held for 4y 2m	$1.65T
P Pale Fire Capital SE Institution	-	$904.1K 0.10% of portfolio	0.61% 153.5K shares	Q4 2024 Held for 11 months	$912.4M

Net Capital Flow

Institutional buying and selling activity for CYBN in Q3 2025

Traded: +$4.3M
Buyers: 40
Sellers: 10
Total Bought: +$12.8M
Total Sold: −$8.5M
Avg Position: $692.5K

Biggest Buyers

Institution	Net Bought	Current Position
R Rosalind Advisors, Inc. Institution	+$4.1M +689.1K shares	$8.8M 1.5M shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity	+$1.5M +248.9K shares	$1.6M 273.8K shares
MORGAN STANLEY RIA/Wealth	+$1.2M +204.8K shares	$1.3M 227.7K shares
UBS Group AG Institution	+$732.1K +124.3K shares	$1.8M 303.7K shares
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy	+$571.9K +97.1K shares	$571.9K 97.1K shares
Marshall Wace LLP Institution	+$511.9K +86.9K shares	$511.9K 86.9K shares
DLD Asset Management, LP Hedge Fund•Multi-Strategy	+$471.2K +80.0K shares	$471.2K 80.0K shares
K Knott David M Jr Institution	+$432.1K +73.4K shares	$826.0K 140.2K shares
MILLENNIUM MANAGEMENT LLC Hedge Fund•Multi-Strategy	+$407.0K +69.1K shares	$407.0K 69.1K shares
P PEAK6 LLC Institution	+$332.3K +56.4K shares	$487.2K 82.7K shares

Biggest Sellers

Institution	Net Sold	Current Position
Deep Track Capital, LP Hedge Fund•Long/Short	−$3.1M −530.0K shares	$5.9M 1.0M shares
Point72 Asset Management, L.P. Hedge Fund•Multi-Strategy	−$2.2M −366.7K shares	$7.3M 1.2M shares
D DCF Advisers, LLC Institution	−$1.7M −202.8K shares	Sold Off 0 shares
B Bollard Group LLC Family Office	−$1.3M −157.0K shares	Sold Off 0 shares
S SPHERA FUNDS MANAGEMENT LTD. Institution	−$164.5K −27.9K shares	$2.2M 370.4K shares
Diametric Capital, LP Hedge Fund•Long/Short	−$28.3K −4.8K shares	$95.0K 16.1K shares
A Advisor Group Holdings, Inc. Institution	−$24.2K −3.5K shares	$28.2K 4.1K shares
RAYMOND JAMES FINANCIAL INC RIA/Wealth	−$11.9K −1.4K shares	Sold Off 0 shares
Crewe Advisors LLC RIA/Wealth	−$8.0K −956.0 shares	Sold Off 0 shares
CarsonAllaria Wealth Management, Ltd. RIA/Wealth	−$109.0 −13.0 shares	Sold Off 0 shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited CYBN in Q3 2025

New Positions: 11
New Value: $1.4M
Exited Positions: 5
Exited Value: $3.0M

New Positions

Institution	Position Value
DLD Asset Management, LP Hedge Fund•Multi-Strategy	$471.2K 80.0K shares
Walleye Trading Advisors, LLC Hedge Fund•Multi-Strategy	$313.6K 53.3K shares
O OXFORD ASSET MANAGEMENT Institution	$299.2K 50.8K shares
A ADAR1 Capital Management, LLC Hedge Fund•Long/Short	$196.0K 33.3K shares
C CREDIT AGRICOLE S A Institution	$93.3K 15.8K shares
Mayflower Financial Advisors, LLC RIA/Wealth	$60.4K 10.3K shares
Sontag Advisory, LLC RIA/Wealth	$1.5K 253.0 shares
HARBOUR INVESTMENTS, INC. RIA/Wealth	$1.5K 250.0 shares
Union Bankshares Corp Institution	$1.5K 250.0 shares
R Root Financial Partners, LLC RIA/Wealth	$383.0 65.0 shares

Exited Positions

Institution	Previous Position
D DCF Advisers, LLC Institution	$1.7M 202.8K shares
B Bollard Group LLC Family Office	$1.3M 157.0K shares
RAYMOND JAMES FINANCIAL INC RIA/Wealth	$11.9K 1.4K shares
Crewe Advisors LLC RIA/Wealth	$8.0K 956.0 shares
CarsonAllaria Wealth Management, Ltd. RIA/Wealth	$109.0 13.0 shares

Options Activity

Institutions with the largest Call and Put options positions in CYBN as of Q3 2025

Call Positions: 5
Call Value: $2.8M
Put Positions: 3
Put Value: $283.9K

Call Positions

Institution	Position Value
DLD Asset Management, LP Hedge Fund•Multi-Strategy	$1.6M 2.8K contracts
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity	$666.2K 1.1K contracts
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy	$374.6K 636.0 contracts
J JANE STREET GROUP, LLC Institution	$99.0K 168.0 contracts
WOLVERINE ASSET MANAGEMENT LLC Hedge Fund•Multi-Strategy	- - contracts

Put Positions

Institution	Position Value
SUSQUEHANNA INTERNATIONAL GROUP, LLP Private Equity	$152.0K 258.0 contracts
CITADEL ADVISORS LLC Hedge Fund•Multi-Strategy	$131.9K 224.0 contracts
WOLVERINE ASSET MANAGEMENT LLC Hedge Fund•Multi-Strategy	- - contracts

Most Committed Institutions

Institutions with CYBN as the highest % of their portfolio as of Q3 2025

Institution	Key People	Portfolio Weight	Ownership	Owned Since	Total AUM (Long)
R Rosalind Advisors, Inc. Institution	-	3.35% $8.8M	5.96% 1.5M shares	Q1 2024 Held for 1y 8m	$263.6M
A ACORN CAPITAL ADVISORS, LLC Venture Capital	Anthony Michael Gallo CCO	2.19% $4.3M	2.92% 734.4K shares	Q4 2024 Held for 11 months	$197.0M
F Fore Capital, LLC Institution	-	1.06% $420.7K	0.28% 71.4K shares	Q3 2024 Held for 1y 2m	$39.6M
S SPHERA FUNDS MANAGEMENT LTD. Institution	-	0.52% $2.2M	1.47% 370.4K shares	Q1 2024 Held for 1y 8m	$416.3M
T TANG CAPITAL MANAGEMENT LLC Institution	-	0.42% $10.8M	7.27% 1.8M shares	Q3 2024 Held for 1y 2m	$2.5B
K Knott David M Jr Institution	-	0.35% $826.0K	0.56% 140.2K shares	Q4 2024 Held for 11 months	$238.7M
Deep Track Capital, LP Hedge Fund•Long/Short	David Eric Kroin CIO	0.17% $5.9M	3.97% 1.0M shares	Q1 2024 Held for 1y 8m	$3.5B
Ikarian Capital, LLC Hedge Fund•Event Driven	Neil Tristan Shahrestani CEO	0.17% $827.4K	0.56% 140.5K shares	Q1 2024 Held for 1y 8m	$494.3M
A AdvisorShares Investments LLC Institution	Noah Hamman CEO	0.11% $683.8K	0.46% 116.1K shares	Q4 2022 Held for 2y 11m	$602.4M
O OXFORD ASSET MANAGEMENT Institution	Henry Stuart Gibson President	0.11% $299.2K	0.20% 50.8K shares	Q3 2025 Held for 2 months	$272.4M

Hedge Fund Spotlight

Discover hedge funds investing in CYBN

Deep Track Capital, LP

Hedge Fund • Long/Short

Portfolio ManagerDavid Eric Kroin

Portfolio Value: $3.5B
Positions: 55
Last Reported: Q3 2025

Sector Allocation

Position in Cybin

Market Value: $5.9M
Shares Held: 1.0M
Portfolio Weight: 0.17%
Owned Since: 2024-Q1

Top Holding	Sector	Market Value	Weight
1 Guardant Health GH	Medical - Diagnostics & Research Healthcare	$259.5M	7.38%
2 Ionis Pharmaceuticals IONS	Biotechnology Healthcare	$249.1M	7.08%
3 Cytokinetics CYTK	Biotechnology Healthcare	$236.3M	6.72%